ENVA Form 144 details: 6,000 shares via Merrill Lynch on NYSE

Rhea-AI Filing Summary

Enova International (ENVA): Form 144 notice filed for an intended sale of common stock. The notice lists 6,000 shares to be sold with an aggregate market value of 720,000, to be executed through Merrill Lynch, with an approximate sale date of 10/27/2025 on the NYSE. Shares outstanding were 24,801,579 as of the disclosure.

The seller acquired 6,000 shares via a stock option on 02/12/2019. Recent activity shows multiple sales in the past three months, including 20,000 shares on 09/04/2025 for 2,438,319.06 and 35,000 shares on 09/17/2025 for 4,392,807.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 110 N Wacker Dr, Ste 1900 Chicago IL 60606	6000	720000	24801579	10/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2019	Stock Option	Enova International			6000	02/12/2019	Stock Option

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/26/2025	5000	588801.44
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/28/2025	15000	1826442.6
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	08/29/2025	10000	1217589.22
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	09/04/2025	20000	2438319.06
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	09/17/2025	35000	4392807
David Fisher 175 West Jackson Blvd, Ste 600 Chicago IL 60604	Common	09/19/2025	6000	755114.3

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)